BioVie Inc.BIVINASDAQ
Loading
R&D Expenses Over TimeContracting
Percentile Rank69
3Y CAGR-33.5%
5Y CAGR-40.7%
Year-over-Year Change
Research and development spending
3Y CAGR
-33.5%/yr
vs +139.7%/yr prior
5Y CAGR
-40.7%/yr
Recent acceleration
Acceleration
-173.3pp
Decelerating
Percentile
P69
Within normal range
vs 5Y Ago
0.1x
Contraction
Streak
1 yr
Consecutive growthContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $9.78M | +5.5% |
| 2025 | $9.27M | -59.9% |
| 2024 | $23.10M | -30.6% |
| 2023 | $33.30M | +92.9% |
| 2022 | $17.26M | -87.0% |
| 2021 | $133.19M | +11475.6% |
| 2020 | $1.15M | +14.1% |
| 2019 | $1.01M | +171.8% |
| 2018 | $370853.00 | -20.5% |
| 2017 | $466354.00 | - |